Decision Tool for Breast Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether a tool called RECONJOINT can assist individuals in making decisions about breast reconstruction surgery after a mastectomy. The researchers aim to determine if this tool is practical for a larger study. Individuals diagnosed with a genetic predisposition to breast cancer or certain types of breast cancer who are considering breast reconstruction might be suitable candidates. The trial includes different groups, such as patients and surgeons, to test the tool’s effectiveness. Participants should be English speakers considering breast reconstruction surgery. As an unphased trial, this study allows participants to contribute to developing a decision-making tool that could benefit future patients considering breast reconstruction.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the RECONJOINT decision aid tool is safe for breast reconstruction surgery?
Research has shown that decision aids like RECONJOINT are generally safe and easy to use. These tools assist patients in making informed choices about their treatment options. Without involving medication or physical procedures, they avoid typical side effects associated with drugs or surgeries.
Studies of similar decision aids have found that patients often feel more informed and comfortable with their choices, leading to less anxiety and greater satisfaction with their treatment decisions. Reports have not linked any negative effects directly to using these decision tools.
Overall, RECONJOINT is expected to be safe for participants, as it aids decision-making without any physical risk.12345Why are researchers excited about this trial?
Researchers are excited about the RECONJOINT decision tool because it aims to enhance decision-making for breast cancer treatment. Unlike standard care, which often relies on a one-size-fits-all approach, RECONJOINT offers personalized guidance by integrating patient preferences with clinical recommendations. This tailored approach could lead to better patient satisfaction and outcomes by ensuring that treatment plans align closely with individual needs and values.
What evidence suggests that the RECONJOINT tool is effective for breast reconstruction surgery?
Research shows that decision aids can help patients make informed choices about their medical care. This trial tests the RECONJOINT tool for individuals considering breast reconstruction surgery. Studies have found that decision aids improve understanding, reduce uncertainty, and increase satisfaction with decisions. Although specific data on RECONJOINT is still being collected, its development draws on positive results from similar tools. This suggests that RECONJOINT could help patients feel more confident and satisfied with their decisions about breast reconstruction.15678
Who Is on the Research Team?
Evan Matros, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center
Are You a Good Fit for This Trial?
This trial is for individuals over 18 years old who have a genetic predisposition to breast cancer or confirmed diagnosis of ductal carcinoma in situ or invasive cancer. They must be considering post-mastectomy breast reconstruction and have an appointment with a plastic surgery provider.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive the RECONJOINT decision aid tool in addition to enhanced usual care
Follow-up
Participants are monitored for feasibility and effectiveness of the decision aid tool
What Are the Treatments Tested in This Trial?
Interventions
- RECONJOINT
Trial Overview
The study is testing the Breast Reconstruction Decision Aid Tool (RECONJOINT) to see if it's helpful for people deciding on breast reconstruction surgery after mastectomy. It aims to determine whether a larger study on this tool would be feasible.
How Is the Trial Designed?
3
Treatment groups
Experimental Treatment
Active Control
Participants in the RECONJOINT intervention arm will receive the decision aid in addition to enhanced usual care
Participating surgeons will be randomized to Enhanced Usual Care or Intervention with a 1:1 ratio
Participants will receive usual care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor
Citations
A Study of a Decision Tool for People Considering Breast ...
The purpose of this study is to find out whether it is practical (feasible) to do a larger study looking at the effectiveness of the Breast Reconstruction ...
Decision Tool for Breast Cancer
The study is testing the Breast Reconstruction Decision Aid Tool (RECONJOINT) to see if it's helpful for people deciding on breast reconstruction surgery after ...
A Decision Tool for Patient-Centered Breast Reconstruction ...
RECONJOINT: A Decision Tool for Patient-Centered Breast Reconstruction Care. Research Grant. Duke Scholars. Brett Thomas Phillips.
Evaluate the effectiveness of breast cancer decision aids
To assess the effectiveness of decision aids in the treatment, prevention and screening of breast cancer patients. A systematic review and meta‐analysis.
Shelby Derene Reed | Duke Clinical Research Institute
RECONJOINT: A Decision Tool for Patient-Centered Breast Reconstruction Care awarded by Memorial Sloan-Kettering Cancer Center 2024 - 2026 ...
6.
towercancer.org
towercancer.org/reconjoint-survey-to-assess-patient-preferences-for-breast-reconstruction/RECONJOINT – Survey to Assess Patient Preferences for ...
We want to learn more about what women value when considering a decision to have breast reconstruction and study how treatment preferences may be different.
making using a decision aid for patients with breast cancer ...
Data collection methods. Data for the following items will be collected: (1) age, gender, height, weight and medical history and (2) information ...
Effects of a web-based decision aid on breast cancer patients ...
The objective of this study was to determine the effects of WDAs on breast cancer patients considering a breast reconstruction.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.